Option chain shows key data for Oculis Holding's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Oculis Holding.

Oculis Holding (NASDAQ:OCS) Stock, Option Chain

Oculis Holding

Overview

News

Earnings

Analyst Ratings

Short Interest

Stock Report

Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

Comments

Oculis Holding Option Chain

No option chain data available. Please try again later